NIH-funded research R01 grant

From Cells to Society: Epigenetics and Brain Vulnerability to Delirium and Cognitive Decline

Official title: From Cells to Society: Using Epigenetics to Understand Brain Vulnerability to Delirium and Cognitive Decline

Funded at Beth Israel Deaconess Medical Center · NIH-11275332 · Data updated 2026-11-12

Researchers will study how DNA methylation patterns (epigenetics) relate to a “vulnerable brain” that could lead to delirium and cognitive decline, especially after major surgery.

More Cognitive Decline research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startJune 15, 2026
Project endFebruary 28, 2031
Funding year2026
Award (this year)$761,496
NIH project number1R01AG097804-01
Project IDNIH-11275332 on NIH RePORTER

Who could benefit from this research

Could help

Older adults (65+), including those with or at risk for AD and related dementias, who are undergoing or have undergone acute stress such as major surgery.

Less likely to help

Individuals under 65 or those without exposure to acute stress or brain vulnerability factors may see limited direct benefit.

What this research studies

This project looks at how epigenetic changes tied to stress influence which people are more likely to experience delirium or faster cognitive decline, including progression toward Alzheimer’s disease. By analyzing DNA methylation and social factors like income and education, the study aims to identify individuals who may be at higher risk during acute stress. The team plans to connect biological signals with clinical outcomes to better predict who might need closer monitoring and intervention after surgery. The work builds on prior findings to move beyond genetics and examine how experience and biology together shape brain resilience in older adults.

Why it matters

Potential benefit: If successful, the research could lead to better risk prediction and personalized strategies to prevent delirium and cognitive decline after surgery.

How similar studies have gone: Previous studies show links between epigenetic changes and brain aging; this project extends those insights to delirium risk in surgical contexts, with promising potential.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Vasunilashorn, Sarinnapha — Beth Israel Deaconess Medical Center
  • Study coordinator: Vasunilashorn, Sarinnapha

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.